MYMD News and Press, MyMD Pharmaceuticals Inc.

2024-06-21 17:32:58 ET More on MyMD Pharmaceuticals Financial information for MyMD Pharmaceuticals Read the full article on Seeking Alpha For further details see: MyMD Pharmaceuticals files to sell 473,841 shares of common stock for holders

Dr. Glass brings a 35-year career in life sciences with multiple drug approvals including Accolate ®, Avandia ® and Coreg® Dr. Glass brings broad expertise in regulatory strategies: 5 NDAs and MAAs, 7 pre-NDA meetings, 12 End of Phase 2 meetings, and more than 80 INDs ...

2024-05-21 10:00:13 ET More on Health Care Select Sector SPDR XLV: Healthcare Is Ripe For Buying, Despite Patent Cliff XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care Short interest in S&P 500 ...

2024-05-21 09:16:11 ET More on MyMD Pharmaceuticals, PharmaCyte Biotech, Inc., etc. Financial information for MyMD Pharmaceuticals Financial information for PharmaCyte Biotech, Inc. Read the full article on Seeking Alpha For further details see: PharmaCyt...

Up to $42 Million in Two-Part Funding from New Strategic Investor and Existing Shareholders with Committed Closing of an Aggregate of $14 Million Up Front MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmac...

2024-04-09 10:00:07 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Well...

China Resources Beer (Holdings) Company Limited ADR (CRHKY) is expected to report for Q4 2023 Melco International Development Ltd. (MDEVF) is expected to report for quarter end 2023-12-31 Meridian Mining UK Societas (MRRDF) is expected to report $0 for Q4 2023 BKF Capital Group Inc (B...

2024-03-05 09:37:57 ET More on MyMD Pharmaceuticals MyMD Pharmaceuticals down after announcing reverse stock split Financial information for MyMD Pharmaceuticals Read the full article on Seeking Alpha For further details see: MyMD Pharmaceuticals said it ...

MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases, autoimmune and inflammatory conditions, today announced that it received notice from ...

2024-02-15 08:02:10 ET MyMD Pharmaceuticals Inc (MYMD) announced stock split at a ratio of 1-for-30 on 2024-02-15 ... Full story available on KlickAnalytics.com